Delivery Order SPE2DB22D3401-SPE2DB25FT0VQ

Award Date 11/20/24
Potential Completion Date 11/21/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp. is a delivery order worth $21,005.14 for the supply of 4558531687 - Lidocaine 5% Patch 30s. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) valued at $7,363.60 for the supply of Lidocaine 5% Patches. The contract is issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order valued at $1,113.39 for the supply of Lidocaine 5% Patches. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp as the prime contractor. This delivery order is part of a larger, single-award Indefinite Delivery Contract (IDC) issued by DLA to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $5,172.00 for the supply of 4564961123 - Lidocaine 5% Patch 30s. The contract, issued by the Defense Logistics Agency (DLA) which is part of the U.S. Department of Defense, does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order contract valued at $3,739.23 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA) and has a period of performance through May 2, 2024. The contract is not designated as a set-aside and appears to be an open competition award. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $1,553.37 for the supply of 4,565,089,492 units of Lidocaine 5% Patch 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen, a major pharmaceutical distribution company, without the use of a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $1,145.06. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of lidocaine 5% patch medical products. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for a delivery order with a firm fixed price of $1,168.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% Patch 30s, a medical product used for pain management. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corporation, the parent company of Amerisourcebergen Drug Corp, is a Delivery Order worth $2,482.56 for the supply of Lidocaine 5% patch 30s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT0VQ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $1,222.44 for the supply of Lidocaine 5% Patches. The award was made by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 and a period of performance through November 2026. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this contract, which does not have a set-aside designation. The contract supports the provision of a wide range of medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order is one of many contract actions under the DLA's comprehensive IDC with Amerisourcebergen, demonstrating the company's role as a key vendor for the federal government's pharmaceutical and medical supply needs.

Generated 2/19/25, 9:23 AM